[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

Workers install 'Alligator Alcatraz' sign for Florida immigration detention center The Biggest Financial Collapse in China’s History Is Here, More Terrifying Than Evergrande! Lightning Cash Jordan NYC Courthouse EMPTIED... ICE Deports 'Entire Building Trump Sparks Domestic Labor Renaissance: Native-Born Workers Surge To Record High As Foreign-Born Plunge Mister Roberts (1965) WE BROKE HIM!! [Early weekend BS/nonsense thread] I'm going to send DOGE after Elon." -Trump This is the America I grew up in. We need to bring it back MD State Employee may get Arrested by Sheriff for reporting an Illegal Alien to ICE RFK Jr: DTaP vaccine was found to have link to Autism FBI Agents found that the Chinese manufactured fake driver’s licenses and shipped them to the U.S. to help Biden... Love & Real Estate: China’s new romance scam Huge Democrat shift against Israel stuns CNN McCarthy Was Right. They Lied About Everything. How Romans Built Domes My 7 day suspension on X was lifted today. They Just Revealed EVERYTHING... [Project 2029] Trump ACCUSED Of MASS EXECUTING Illegals By DUMPING Them In The Ocean The Siege (1998) Trump Admin To BAN Pride Rainbow Crosswalks, DoT Orders ALL Distractions REMOVED Elon Musk Backing Thomas Massie Against Trump-AIPAC Challenger Skateboarding Dog Israel's Plans for Jordan Daily Vitamin D Supplementation Slows Cellular Aging: Hepatitis E Virus in Pork Hospital Executives Arrested After Nurse Convicted of Killing Seven Newborns, Trying to Kill Eight More The Explosion of Jewish Fatigue Syndrome Tucker Carlson: RFK Jr's Mission to End Skyrocketing Autism, Declassifying Kennedy Files Israel has killed 1,000 Palestinians in the West Bank since October 7, 2023

Health
See other Health Articles

Title: Aust'n researchers prevent progression of diabetic kidney disease for first time
Source: [None]
URL Source: [None]
Published: Feb 10, 2017
Author: staff
Post Date: 2017-02-10 04:44:40 by Tatarewicz
Keywords: None
Views: 42
Comments: 1

SYDNEY, Feb. 10 (Xinhua) -- An Australian pharmaceutical company has successfully prevented the progression of Diabetic Kidney Disease (DKD) for the first time.

DKD is an often fatal long-term complication of type 2 diabetes which is the most common cause of severe renal disease. It affects one third of people with type 2 diabetes and has no viable treatment until now.

An international team of scientists in collaboration with Melbourne-based global biotechnology leader CSL Limited investigated a therapeutic approach that targets the transport of fatty acids, or lipids, from the blood into tissues to treat DKD.

Using 2H10, an antibody developed by CSL, the researchers were able to block Vascular Endothelial Growth Factor B (VEGF-B), a protein that affects the transport of lipids into body tissue. Elevated levels of VEGF-B are a common symptom among patients with DKD.

By inhibiting VEGF-B signalling the researchers were able to reduce the accumulation of lipid deposits within the kidney and moderate the progression of kidney disease in a number of models of type 1 and 2 diabetes.

Andrew Nash, Senior Vice President of Research at CSL, said the finding could save lives.

"This research addresses an important area of unmet medical need and could lead to an entirely new approach to the treatment of type 2 diabetes," Nash said in a media release on Friday.

Professor Ulf Eriksson, the lead researcher on the study, said that "the study reveals some mechanistic understanding of the disease progression and challenges the hypothesis that diabetic kidney disease is simply the result of chronic elevated blood glucose."

The study, which was published in respected journal Cell Metabolism on Friday, was carried out on mice but a human trial of the protein in humans with DKD has been flagged for the near future. Editor: ying

Post Comment   Private Reply   Ignore Thread  

#1. To: Tatarewicz (#0)

The study, which was published in respected journal Cell Metabolism on Friday, was carried out on mice but a human trial of the protein in humans with DKD has been flagged for the near future.

Can't come too soon.

sneakypete  posted on  2017-02-10   5:23:39 ET  Reply   Trace   Private Reply  

[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]